HEADER TRANSFERASE/TRANSFERASE INHIBITOR 29-NOV-00 1GAG TITLE CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A TITLE 2 BISUBSTRATE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN RECEPTOR, TYROSINE KINASE DOMAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TYROSINE KINASE DOMAIN; COMPND 5 SYNONYM: IR; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: BISUBSTRATE PEPTIDE INHIBITOR; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: PHE107 OF PEPTIDE 13-MER MODIFIED BY ATP GAMMA S PLUS COMPND 14 FOUR-ATOM LINKER, RESIDUE 112 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS PROTEIN KINASE INHIBITOR, TYROSINE KINASE, TRANSFERASE, SIGNALING KEYWDS 2 PROTEIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.PARANG,J.H.TILL,A.J.ABLOOGLU,R.A.KOHANSKI,S.R.HUBBARD,P.A.COLE REVDAT 8 15-NOV-23 1GAG 1 REMARK REVDAT 7 09-AUG-23 1GAG 1 REMARK REVDAT 6 27-OCT-21 1GAG 1 REMARK SEQADV LINK REVDAT 5 13-JUL-11 1GAG 1 VERSN REVDAT 4 22-SEP-09 1GAG 1 SEQADV REVDAT 3 24-FEB-09 1GAG 1 VERSN REVDAT 2 24-JAN-01 1GAG 1 AUTHOR REVDAT 1 17-JAN-01 1GAG 0 JRNL AUTH K.PARANG,J.H.TILL,A.J.ABLOOGLU,R.A.KOHANSKI,S.R.HUBBARD, JRNL AUTH 2 P.A.COLE JRNL TITL MECHANISM-BASED DESIGN OF A PROTEIN KINASE INHIBITOR. JRNL REF NAT.STRUCT.BIOL. V. 8 37 2001 JRNL REFN ISSN 1072-8368 JRNL PMID 11135668 JRNL DOI 10.1038/83028 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.R.HUBBARD REMARK 1 TITL CRYSTAL STRUCTURE OF THE ACTIVATED INSULIN RECEPTOR TYROSINE REMARK 1 TITL 2 KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG REMARK 1 REF EMBO J. V. 16 5572 1997 REMARK 1 REFN ISSN 0261-4189 REMARK 1 DOI 10.1093/EMBOJ/16.18.5572 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.8 REMARK 3 NUMBER OF REFLECTIONS : 9342 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 501 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2460 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 23 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.93100 REMARK 3 B22 (A**2) : 4.93100 REMARK 3 B33 (A**2) : -9.86200 REMARK 3 B12 (A**2) : -4.32400 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.753 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.964 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.620 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.591 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.380 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 10.14 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GAG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1000012429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42217 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.11400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.33900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1IR3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, TRIS-HCL, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 92.06667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.03333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 46.03333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 92.06667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -86.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 -99.45000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 57.41748 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 978 REMARK 465 PHE A 979 REMARK 465 PRO A 980 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 988 CG CD OE1 OE2 REMARK 470 ASN A1014 CG OD1 ND2 REMARK 470 ARG A1016 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1024 CG CD OE1 OE2 REMARK 470 GLU A1034 CG CD OE1 OE2 REMARK 470 LYS A1068 CG CD CE NZ REMARK 470 GLN A1070 CG CD OE1 NE2 REMARK 470 GLU A1094 CG CD OE1 OE2 REMARK 470 GLU A1096 CG CD OE1 OE2 REMARK 470 LYS A1168 CG CD CE NZ REMARK 470 ARG A1243 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1280 CG CD OE1 OE2 REMARK 470 LYS A1283 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1007 22.13 -148.09 REMARK 500 ASP A1017 78.02 40.85 REMARK 500 MET A1079 79.06 -107.28 REMARK 500 ALA A1080 -53.94 -19.86 REMARK 500 LYS A1127 52.84 73.71 REMARK 500 ARG A1131 -9.91 72.33 REMARK 500 ASP A1132 54.19 -143.19 REMARK 500 ASP A1150 88.74 39.42 REMARK 500 ARG A1174 -1.72 -59.72 REMARK 500 ALA B 103 64.90 -57.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 21 O REMARK 620 2 HOH A 22 O 100.5 REMARK 620 3 ASP A1150 OD2 72.3 125.3 REMARK 620 4 HOH B 20 O 111.2 93.7 140.3 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A1137 OD1 REMARK 620 2 ASP A1150 OD2 107.4 REMARK 620 3 HOH B 1 O 95.1 83.3 REMARK 620 4 112 B 101 O2S 79.6 90.4 170.3 REMARK 620 5 112 B 101 O2G 89.4 163.2 95.9 92.2 REMARK 620 6 112 B 101 O2B 169.6 79.7 77.9 108.3 83.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 112 B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF BISUBSTRATE PEPTIDE REMARK 800 INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IR3 RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH AN ATP ANALOG AND PEPTIDE REMARK 900 SUBSTRATE DBREF 1GAG A 978 1283 UNP P06213 INSR_HUMAN 1005 1310 DBREF 1GAG B 102 114 PDB 1GAG 1GAG 102 114 SEQADV 1GAG SER A 981 UNP P06213 CYS 1008 ENGINEERED MUTATION SEQADV 1GAG PHE A 984 UNP P06213 TYR 1011 ENGINEERED MUTATION SEQADV 1GAG PTR A 1158 UNP P06213 TYR 1185 MODIFIED RESIDUE SEQADV 1GAG PTR A 1162 UNP P06213 TYR 1189 MODIFIED RESIDUE SEQADV 1GAG PTR A 1162 UNP P06213 TYR 1190 MODIFIED RESIDUE SEQRES 1 A 306 VAL PHE PRO SER SER VAL PHE VAL PRO ASP GLU TRP GLU SEQRES 2 A 306 VAL SER ARG GLU LYS ILE THR LEU LEU ARG GLU LEU GLY SEQRES 3 A 306 GLN GLY SER PHE GLY MET VAL TYR GLU GLY ASN ALA ARG SEQRES 4 A 306 ASP ILE ILE LYS GLY GLU ALA GLU THR ARG VAL ALA VAL SEQRES 5 A 306 LYS THR VAL ASN GLU SER ALA SER LEU ARG GLU ARG ILE SEQRES 6 A 306 GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLY PHE THR SEQRES 7 A 306 CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SER LYS SEQRES 8 A 306 GLY GLN PRO THR LEU VAL VAL MET GLU LEU MET ALA HIS SEQRES 9 A 306 GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG PRO GLU SEQRES 10 A 306 ALA GLU ASN ASN PRO GLY ARG PRO PRO PRO THR LEU GLN SEQRES 11 A 306 GLU MET ILE GLN MET ALA ALA GLU ILE ALA ASP GLY MET SEQRES 12 A 306 ALA TYR LEU ASN ALA LYS LYS PHE VAL HIS ARG ASP LEU SEQRES 13 A 306 ALA ALA ARG ASN CYS MET VAL ALA HIS ASP PHE THR VAL SEQRES 14 A 306 LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE PTR GLU SEQRES 15 A 306 THR ASP PTR PTR ARG LYS GLY GLY LYS GLY LEU LEU PRO SEQRES 16 A 306 VAL ARG TRP MET ALA PRO GLU SER LEU LYS ASP GLY VAL SEQRES 17 A 306 PHE THR THR SER SER ASP MET TRP SER PHE GLY VAL VAL SEQRES 18 A 306 LEU TRP GLU ILE THR SER LEU ALA GLU GLN PRO TYR GLN SEQRES 19 A 306 GLY LEU SER ASN GLU GLN VAL LEU LYS PHE VAL MET ASP SEQRES 20 A 306 GLY GLY TYR LEU ASP GLN PRO ASP ASN CYS PRO GLU ARG SEQRES 21 A 306 VAL THR ASP LEU MET ARG MET CYS TRP GLN PHE ASN PRO SEQRES 22 A 306 LYS MET ARG PRO THR PHE LEU GLU ILE VAL ASN LEU LEU SEQRES 23 A 306 LYS ASP ASP LEU HIS PRO SER PHE PRO GLU VAL SER PHE SEQRES 24 A 306 PHE HIS SER GLU GLU ASN LYS SEQRES 1 B 13 PRO ALA THR GLY ASP PHE MET ASN MET SER PRO VAL GLY MODRES 1GAG PTR A 1158 TYR O-PHOSPHOTYROSINE MODRES 1GAG PTR A 1162 TYR O-PHOSPHOTYROSINE MODRES 1GAG PTR A 1163 TYR O-PHOSPHOTYROSINE HET PTR A1158 16 HET PTR A1162 16 HET PTR A1163 16 HET MG A 201 1 HET MG A 202 1 HET 112 B 101 35 HETNAM PTR O-PHOSPHOTYROSINE HETNAM MG MAGNESIUM ION HETNAM 112 THIOPHOSPHORIC ACID O-((ADENOSYL-PHOSPHO)PHOSPHO)-S- HETNAM 2 112 ACETAMIDYL-DIESTER HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 3(C9 H12 N O6 P) FORMUL 3 MG 2(MG 2+) FORMUL 5 112 C12 H19 N6 O13 P3 S FORMUL 6 HOH *23(H2 O) HELIX 1 1 SER A 981 VAL A 985 5 5 HELIX 2 2 SER A 992 GLU A 994 5 3 HELIX 3 3 SER A 1037 GLY A 1053 1 17 HELIX 4 4 ASP A 1083 LEU A 1091 1 9 HELIX 5 5 THR A 1105 LYS A 1126 1 22 HELIX 6 6 ALA A 1134 ARG A 1136 5 3 HELIX 7 7 PRO A 1172 MET A 1176 5 5 HELIX 8 8 ALA A 1177 GLY A 1184 1 8 HELIX 9 9 THR A 1187 SER A 1204 1 18 HELIX 10 10 SER A 1214 ASP A 1224 1 11 HELIX 11 11 PRO A 1235 TRP A 1246 1 12 HELIX 12 12 ASN A 1249 ARG A 1253 5 5 HELIX 13 13 THR A 1255 LYS A 1264 1 10 HELIX 14 14 ASP A 1265 LEU A 1267 5 3 HELIX 15 15 SER A 1270 SER A 1275 1 6 HELIX 16 16 ALA B 103 PHE B 107 5 5 SHEET 1 A 5 ILE A 996 GLY A1005 0 SHEET 2 A 5 GLY A1008 ILE A1019 -1 O GLY A1008 N GLY A1005 SHEET 3 A 5 GLU A1022 LYS A1030 -1 N GLU A1022 O ILE A1019 SHEET 4 A 5 LEU A1073 GLU A1077 -1 O VAL A1074 N LYS A1030 SHEET 5 A 5 LEU A1062 VAL A1066 -1 N LEU A1063 O VAL A1075 SHEET 1 B 2 PHE A1128 VAL A1129 0 SHEET 2 B 2 ARG A1155 ASP A1156 -1 O ARG A1155 N VAL A1129 SHEET 1 C 2 CYS A1138 VAL A1140 0 SHEET 2 C 2 VAL A1146 ILE A1148 -1 O LYS A1147 N MET A1139 SHEET 1 D 2 GLY A1169 LEU A1171 0 SHEET 2 D 2 MET B 108 MET B 110 -1 O MET B 108 N LEU A1171 LINK C ILE A1157 N PTR A1158 1555 1555 1.33 LINK C PTR A1158 N GLU A1159 1555 1555 1.33 LINK C ASP A1161 N PTR A1162 1555 1555 1.33 LINK C PTR A1162 N PTR A1163 1555 1555 1.33 LINK C PTR A1163 N ARG A1164 1555 1555 1.33 LINK NS 112 B 101 CZ PHE B 107 1555 1555 1.45 LINK O HOH A 21 MG MG A 202 1555 1555 1.58 LINK O HOH A 22 MG MG A 202 1555 1555 2.39 LINK MG MG A 201 OD1 ASN A1137 1555 1555 2.32 LINK MG MG A 201 OD2 ASP A1150 1555 1555 2.06 LINK MG MG A 201 O HOH B 1 1555 1555 2.37 LINK MG MG A 201 O2S 112 B 101 1555 1555 2.20 LINK MG MG A 201 O2G 112 B 101 1555 1555 2.31 LINK MG MG A 201 O2B 112 B 101 1555 1555 1.86 LINK MG MG A 202 OD2 ASP A1150 1555 1555 3.13 LINK MG MG A 202 O HOH B 20 1555 1555 2.16 CISPEP 1 GLN A 1070 PRO A 1071 0 -0.42 SITE 1 AC1 4 ASN A1137 ASP A1150 HOH B 1 112 B 101 SITE 1 AC2 5 HOH A 21 HOH A 22 ASP A1150 HOH B 20 SITE 2 AC2 5 112 B 101 SITE 1 AC3 21 MG A 201 MG A 202 LEU A1002 GLY A1005 SITE 2 AC3 21 SER A1006 VAL A1010 ALA A1028 LYS A1030 SITE 3 AC3 21 GLU A1077 MET A1079 ASP A1083 ASP A1132 SITE 4 AC3 21 ARG A1136 ASN A1137 ASP A1150 HOH B 1 SITE 5 AC3 21 HOH B 14 HOH B 20 PRO B 102 ALA B 103 SITE 6 AC3 21 PHE B 107 SITE 1 AC4 19 GLN A1004 GLU A1094 ARG A1136 GLY A1167 SITE 2 AC4 19 LYS A1168 GLY A1169 LEU A1170 LEU A1171 SITE 3 AC4 19 PRO A1172 VAL A1173 TRP A1175 LEU A1181 SITE 4 AC4 19 LYS A1182 ASP A1183 GLY A1184 ASN A1215 SITE 5 AC4 19 ASP A1232 HOH B 6 112 B 101 CRYST1 66.300 66.300 138.100 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015083 0.008708 0.000000 0.00000 SCALE2 0.000000 0.017416 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007241 0.00000